drugset / Trial / NCT00850421

Pilot Study of BOTOX for Migraine Headaches

NCT00850421

NaSingle-groupOpen-labelTreatment

Summary

The purposes of this study are to assess whether subjects treated with BOTOX will: 1. have a decrease in the frequency and intensity of migraine headaches 2. experience improvements in quality of life 3. experience a reduction in the frequency of health care services obtained.

Timeline

Start
2004-04
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu

Indications